Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation

详细信息	查看全文 | 推荐本文 |

• 作者：Cristina Montiel-Duarte ; Lucia Cordeu ; Xabier Agirre ; José ; Romá ; n-G&#xf3 ; mez ; Antonio Jimé ; nez-Velasco ; Edurne San José ; -Eneriz ; Leire Gá ; rate ; Enrique J. Andreu ; Maria José
• 关键词：PTEN ; Ph⁺ ALL ; Imatinib ; PI3K AKT
• 刊名：Leukemia Research
• 出版年：2008
• 期刊代码：186_01452126
• 类别：med
• 出版时间：May 2008
• 卷：32
• 期：5
• 页码：709-716
• 文件大小：473 K

摘要

The aim of our study was to determine the potential mechanism(s) implicated in Imatinib resistance in patients with Ph⁺ ALL. Resistance of Ph⁺ ALL cells to Imatinib-induced apoptosis was associated with lack of inhibition of Akt phosphorylation. Addition of the PI3K inhibitor LY294002 to Imatinib significantly increased apoptosis of Ph⁺ ALL cells. Interestingly, expression of PTEN was reduced in Ph⁺ ALL cells which was due to PTEN promoter hypermethylation. Treatment of Ph⁺ ALL cells with 5-Aza-2′-deoxycytidine was associated with an increased expression of PTEN and an increase in cell apoptosis. These results suggest that Imatinib resistance in patients with ALL may be dependent at least in part to PTEN down-regulation due to the abnormal promoter hypermethylation and support the potential role of de-methylating agents for the treatment of patients with Ph⁺ ALL.